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Objectives: Cigarette smoking has been shown in European populations to be 
associated with rheumatoid arthritis (RA) susceptibility. This study aims to examine the 
association of smoking with RA in the Han Chinese population.
Methods: 718 Han Chinese RA patients and 404 healthy controls were studied. The 
associations of cigarette smoking (current, former or ever vs. never smokers, and pack-
years of exposure) with RA, anti-cyclic citrullinated peptide antibody (ACPA) positive RA, 
IgM rheumatoid factor (RF) positive RA, and baseline radiographic erosions (modified 
van der Heijde–Sharp scores) were assessed. The interaction between smoking and the 
HLA-DRB1 shared epitope (SE) in RA was also examined.
results: In this study, 11 (1.53%) cases and 6 (1.49%) controls were former smokers 
(p = 0.95), while 95 (13.23%) cases and 48 (11.88%) controls were current smokers 
(p = 0.52). Trends toward associations between smoking status (ever vs. never) with 
RA-overall (p = 0.15, OR = 1.44), ACPA-positive RA (p = 0.24, OR = 1.37), RF-positive 
RA (p = 0.14, OR = 1.46), or the presence of radiographic erosions (p = 0.66, OR = 1.28) 
were observed although individually here were not statistically significant. There was no 
evidence of statistical interaction between smoking status (ever vs. never) and SE for all 
RA, ACPA-positive RA, ACPA-negative RA, RF-positive RA, RF-negative RA (p = 0.37, 
0.50, 0.24, 0.26, and 0.81 respectively), and the 95% CI for the attributable proportion 
for all interactions included 0.
conclusion: This is the first study to examine the association of cigarette smoking 
with RA in the Han Chinese population. This study shows a trend toward an interaction 
between smoking and SE carriage influencing the risk of RA, though findings were not 
statistically significant. It is possible that in the presence of universal exposure to heavy 
air pollution the effect of smoking on RA risk may be obscured.
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inTrODUcTiOn
Rheumatoid arthritis (RA) is a complex immune-mediated 
disease that is thought to arise due to the interacting effects of 
environmental and genetic factors. Several studies performed in 
populations of European ancestry have suggested that smoking 
is an environmental risk factor increasing the risk of RA (1–3). 
Carriage of the HLA-DRB1 shared epitope (SE) is the most 
important genetic risk factor for RA, accounting for approxi-
mately 40% of genetic susceptibility to the disease (4). Several 
studies have reported that smoking interacts with HLA-DRB1 in 
increasing the risk of anti-cyclic citrullinated peptide antibody 
(ACPA)-positive, but not ACPA-negative, RA (5–7). This sug-
gests that the pathogenesis of ACPA-positive RA might differ 
from that of ACPA-negative disease (8), although the extensive 
sharing of genetic associations between the two subtypes of 
RA (9) indicates that they have marked similarity of genetic 
architecture.
The studies showing that cigarette smoking was associated 
with RA and ACPA risk have almost exclusively involved popula-
tions of Caucasian ancestry. Evidence of association of smoking 
specifically with ACPA-positive RA has thus far been restricted 
to studies of European-descent ethnic groups. Studies in Koreans 
and in African-Americans have found that while smoking 
increased the risk of developing RA-overall, the association was 
not restricted to ACPA-positive disease (10, 11). Smoking rates in 
Chinese are very high, with 52.7% of males being ever smokers. 
While smoking rates in women are lower (about 2.4%) they are 
increasing (12). Therefore, it is of great relevance to investigate the 
role of smoking in the Han Chinese population with RA.
MaTerials anD MeThODs
Patients and controls
Among these 718 cases, 191 were recruited from Shanghai 
Changzheng Hospital, 349 from Shanghai Guanghua Hospital, 
49 from Shanghai Tongji Hospital, 28 from Peking Union Medical 
College Hospital, and 91 Huaxi Hospital. All patients were diag-
nosed in accordance with the American College of Rheumatology 
1987 classification criteria (13). 404 healthy controls (blood 
donors on no prescription medications) were recruited from 
Shanghai. All human studies have been approved by the Research 
Ethical Committee of Second Military Medical University, and 
all patients and controls gave informed written consent for their 
participation in the studies. Patient charts were reviewed to 
collect the patients’ demographic information, disease duration, 
and smoking history before the disease onset. Questionnaires 
were designed to collect the controls’ demography and smoking 
information. We defined who ever smoked cigarette as smokers. 
We also defined ≥10 pack-years as heavy smoker when assessing 
smoking cumulative effect. EDTA preserved blood was collected 
from all cases and controls for DNA extraction, and serum 
samples from all cases. Radiographs of the hands and wrists 
were obtained at recruitment and scored by two independent 
experienced radiologists using the modified van der Heijde–
Sharp score in 517 of 718 cases. Patients with available scores 
were classified as having either erosive disease (Sharp erosion 
score > 0) or non-erosive disease (Sharp erosion score = 0) (14).
IgG ACPA titers were measured by a commercially available 
second generation (CCP2) enzyme-linked immunosorbent assay 
(ELISA, EUROIMMUN, Lubeck, Germany) and were consid-
ered to be positive at a cut of value >5 IU/ml in accordance to 
the instructions of manufacturer. IgM rheumatoid factor (RF) 
was measured by ELISA (EUROIMMUN, Lubeck, Germany) 
and considered to be positive when the titers were ≥20 RU/ml.
Sequence-specific primer-polymerase chain reaction method 
was used to determine carriage of HLA-DRB1*01, HLA-DRB1*04, 
and HLA-DRB1*10 alleles (15), and HLA-DRB1*0101, *0102, 
*0401, *0404, *0405, *0408, and *1001 were defined as SE.
statistical analysis
Differences of gender, smoking, and SE carriage between groups 
were investigated using the chi-squared test, and Student’s t-test 
was used to examine the differences of age between cases and 
controls. Logistic regression was used to examine the association 
of smoking (ever smokers vs. never smokers, <10 pack-years and 
never vs. ≥10 pack-years) with affection status, ACPA carriage, 
RF-IgM positive disease, and baseline radiographic erosions, 
adjusting for SE status (positive or negative), age, and gender 
given the differences in these characteristics between cases and 
controls.
Logistic regression analysis was used to calculate the asso-
ciation of smoking–SE interaction with all patients, carriage of 
ACPA or RF, and radiographic erosions (16). The attributable 
proportion (AP) due to interaction (where an AP = 0 corresponds 
to no interaction and an AP =  1.0 corresponds to “complete” 
interaction) and corresponding 95% confidence intervals were 
calculated (17). A p-value of <0.05 was considered statistically 
significant. All analyses were conducted using SPSS13.0 (Chicago, 
IL, USA).
resUlTs
Characteristics of cases and controls are shown in Table 1. Cases 
and controls were well matched for gender (77.44 vs. 75.74% 
female, p = 0.52), but RA cases were older than controls (53.19 vs. 
44.56 years, p < 0.01). The mean disease duration from onset of 
symptoms in cases was 7.54 (8.14) years. HLA-DRB1 SE positivity 
was much higher in RA cases than in controls (40.11 vs. 19.06%, 
odds ratio 15.8, p = 4.3 × 10−84). The differences of SE subtypes 
between two groups were shown in Table 2. 566 (78.83%) and 
574 (79.94%) cases were ACPA and RF-positive, respectively. 462 
cases (89.36%) had baseline radiographic erosions. 11 (1.53%) 
cases and 6 (1.49%) controls were former smokers while 95 
(13.23%) cases and 48 (11.88%) controls were current smokers. 
Smoking status was not associated with affection status (p = 0.95 
and p = 0.52 for former and current smokers, respectively), even 
among heavy smokers (defined as ≥10 pack-years; 13.79 vs. 
11.39%, p = 0.25).
In sex–age–SE adjusted analysis (Table  3), there was no 
association between smoking status (Table  3, A, former and 
current vs. never) with either RA-overall (p = 0.89 and p = 0.13, 
TaBle 2 | Differences of shared epitope (SE) alleles between rheumatoid arthritis 
(RA) and healthy control.
se alleles ra (%) control (%) p-Value Or (95% ci)
HLA-DRB1*0401 22 (3.06) 18 (4.46) 0.23 0.68 (0.36–1.28)
HLA-DRB1*0404 27 (3.76) 13 (3.22) 0.64 1.18 (0.56–2.30)
HLA-DRB1*0405 165 (22.98) 44 (10.89) <0.01 2.54 (1.78–3.63)
HLA-DRB1*0408 21 (2.92) 3 (0.74) 0.02 4.03 (1.19–13.59)
HLA-DRB1*0101 19 (2.65) 3 (0.74) 0.03 3.63 (1.07–12.35)
HLA-DRB1*0102 0 0 0 0
HLA-DRB1*1001 64 (8.91) 10 (2.48) <0.01 3.86 (1.96–7.60)
Differences of SE alleles were calculated by chi-square test.
TaBle 1 | Characteristics of Chinese Han rheumatoid arthritis (RA) cases and 
healthy controls; means (±SD) or %.
ra cases 
(n = 718)
controls  
(n = 404)
p-Value
Female sex 556 (77.44%) 306 (75.74%) 0.52
Age, years 53.19 (13.61) 44.56 (9.27) <0.01
Disease duration at  
baseline visit, years
7.54 (8.14)
Shared epitope positive 288 (40.11%) 77 (19.06%) <0.01
Anti-CCP antibody positive 566 (78.83%) 7 (1.70%) <0.01
RF-positive 574 (79.94%) 81 (20.00%) <0.01
Bone erosion 462 (89.36%)
Smoking status
Never 612 (85.25%) 350 (86.63%)
Former 11 (1.53%) 6 (1.49%) 0.95
Current 95 (13.23%) 48 (11.88%) 0.52
Cumulative smoking exposure
Never or <10 pack-years 619 (86.21%) 358 (88.61%)
Ever ≥10 pack-years 99 (13.79%) 46 (11.39%) 0.25
CCP, cyclic citrullinated peptide; RF, rheumatoid factor.
p-Values calculated using chi-square test or Student’s t-test.
201 cases missed the radiographic information.
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respectively), ACPA-positive RA (p = 0.93 and p = 0.20, respec-
tively), RF-positive RA (p = 0.87 and p = 0.12, respectively), or 
the presence of radiographic erosions (p =  0.81 and p =  0.68, 
respectively). There was also no association between smoking 
status (Table  3, B, ever vs. never) with RA-overall (p =  0.15), 
ACPA-positive RA (p =  0.24), RF-positive RA (p =  0.14), or 
the presence of radiographic erosions (p =  0.66). Cumulative 
smoking (Table  3, C, cumulative exposure vs. never) was also 
not associated with RA-overall (p =  0.15), ACPA-positive RA 
(p = 0.25), RF-positive RA (p = 0.12), or radiographic erosions 
(p = 0.55).
The assessment of interaction between HLA-DRB1 SE (posi-
tive or negative) and smoking (ever or never) in RA was shown 
in Table 4. After adjustment for age and gender, and consider-
ing never smoking/SE-negative as the reference, ORs (95% CI) 
of ever smoking/SE-negative, never smoking/SE-positive, and 
ever smoking/SE-positive in all RA were 1.52 (0.88–2.60), 2.82 
(2.01–3.95), and 3.46 (1.50–7.95), respectively (p = 0.13, <0.01, 
and <0.01, respectively). In ACPA-positive RA, for the same cat-
egories, the ORs (95% CI) were 1.41 (0.79–2.49), 2.86 (2.02–4.06), 
and 3.62 (1.53–8.55), respectively (p = 0.24, <0.01, and <0.01, 
respectively). In ACPA-negative RA, again for the same categories, 
ORs (95% CI) RA were 1.70 (0.69–4.19), 3.11 (1.83–5.29), and 
2.07 (0.66–10.37), respectively (p = 0.25, <0.01, and 0.17, respec-
tively). In RF-positive RA, for the same categories, ORs (95% CI) 
in RF-positive RA were 1.66 (0.91–2.82), 2.92 (2.07–4.14), and 
3.25 (1.36–7.75), respectively (p  =  0.10, <0.01, and 0.008, 
respectively), and in RF-negative RA were 0.86 (0.32–2.27), 3.10 
(1.81–5.30), and 3.97 (1.88–12.88), respectively (p = 0.25, <0.01, 
and 0.17, respectively). There was no evidence of statistical 
interaction between smoking status (never, ever) and SE for all 
RA, ACPA-positive RA, ACPA-negative RA, RF-positive RA, 
RF-negative RA (p = 0.37, 0.50, 0.24, 0.26, and 0.81 respectively), 
and the 95% CI for the AP for all interactions included 0.
Assessment of interaction between HLA-DRB1 SE (positive 
or negative) and cumulative smoking exposure (≥10 pack-years, 
<10  pack-years or never smoker was defined as other) in RA 
was shown in Table 5. After adjustment for age and gender and 
considering never smoking/SE-negative as the reference, ORs 
(95% CI) of heavy smoking/SE-negative, other/SE-positive, 
heavy smoking/SE-positive in all RA were 1.46 (0.85–2.53), 2.77 
(1.99–3.86), and 3.81 (1.53–9.78) (p =  0.17, <0.01, and <0.01, 
respectively). In ACPA-positive RA, these ORs (95% CI) were 1.36 
(0.76–2.43), 2.83 (2.01–3.99), and 3.89 (1.50–10.09), respectively 
(p = 0.30, <0.01, and <0.01, respectively) and in ACPA-negative 
RA were 1.61 (0.65–3.96), 2.98 (1.76–5.05), and 3.24 (0.75–13.92), 
respectively (p = 0.30, <0.01, and 0.12, respectively). Considering 
RF-positive RA, for the same categories ORs (95% CI) were 1.58 
(0.89–2.79), 2.85 (2.02–4.01), and 3.83 (1.47–9.98), respectively 
(p = 0.12, <0.01, and <0.01, respectively), and in RF-negative RA 
were 0.67 (0.29–2.12), 3.13 (1.85–5.30), and 3.67 (0.99–13.67), 
respectively (p = 0.63, <0.01, and 0.05, respectively). No statisti-
cal interaction between cumulative smoking exposure and SE was 
observed among all RA cases or in ACPA-positive or negative, or 
RF-positive or negative cases (p = 0.61, 0.81, 0.69, 0.62, and 0.75), 
and the 95% CI for the AP these analyses always included 0.
As shown in Tables 4 and 5, ORs of ever smoking/SE-negative, 
never smoking/SE-positive, and ever smoking/SE-positive for 
radiographic erosions were 1.22 (0.34–4.38), 1.03 (0.55–1.92), 
and 1.45 (0.28–7.64), respectively, and for heavy smoking/
SE-negative, other/SE-positive, and heavy smoking/SE-positive 
were 1.01 (0.55–1.85), 1.59 (0.44–5.70), and 1.13 (0.22–5.88), 
respectively (all p >  0.05). There was no smoking (cumulative 
smoking)–SE interaction for radiographic erosions (p  =  0.84 
and 0.75, respectively), and the 95% CI for the AP for all these 
analyses also included 0.
DiscUssiOn
To the best of our knowledge, this is the first study to evaluate 
the association of cigarette smoking with RA in the Han Chinese 
population. The results of our study showed that while smoking 
was not significantly associated with RA, serological positive RA, 
or radiographic erosions in Chinese patients trends toward asso-
ciations were noticed in nearly all analyses. Based on previous 
studies (5–7), Klareskog et al. hypothesized that smoking might 
trigger citrullination in the lungs of the individuals who carry 
the HLA-DRB1 SE, thereby providing a substrate for immune 
activation that finally causes ACPA-positive RA (8). However, 
TaBle 3 | Age–gender–SE adjusted associations of cigarette smoking (smoking status and cumulative smoking exposure) with rheumatoid arthritis (RA) and baseline radiographic erosions in  
Chinese Han population.
(a) age–gender–se adjusted associations of cigarette smoking with ra and baseline radiographic erosions in chinese han population
smoking status all ra anti-ccP positive ra anti-ccP negative ra rF-positive ra rF-negative ra radiographic erosions
Never Referent Referent Referent Referent Referent Referent
Former OR (95% CI) 1.09 (0.33–3.54) 0.94 (0.26–3.45) 1.86 (0.34–10.14) 1.11 (0.32–3.85) 1.20 (0.18–7.99) 0.76 (0.08–7.25)
p-Value 0.89 0.93 0.47 0.87 0.85 0.81
Current OR (95% CI) 1.49 (0.89–2.49) 1.43 (0.83–2.44) 1.37 (0.58–3.23) 1.53 (0.89–2.60) 0.97 (0.42–2.27) 1.29 (0.39–4.23)
p-Value 0.13 0.20 0.47 0.12 0.95 0.68
(B) age-gender-se adjusted associations of ever smoking with ra and baseline radiographic erosions in chinese han population
smoking status all ra anti-ccP positive ra anti-ccP negative ra rF-positive ra rF-negative ra radiographic erosions
Never Referent Referent Referent Referent Referent Referent
Ever OR (95% CI) 1.44 (0.88–2.37) 1.37 (0.81–2.31) 1.42 (0.63–3.24) 1.46 (0.88–2.41) 0.99 (0.44–2.25) 1.28 (0.42–3.92)
p-Value 0.15 0.24 0.40 0.14 0.98 0.66
(c) age-gender-se adjusted associations of cumulative smoking with ra and baseline radiographic erosions in chinese han population
cumulative exposure all ra anti-ccP positive ra anti-ccP negative ra rF-positive ra rF-negative ra radiographic erosions
Never/<10 pack-years Referent Referent Referent Referent Referent Referent
Ever, ≥10 pack-years OR (95% CI) 1.45 (0.88–2.40) 1.37 (0.80–2.32) 1.47 (0.64–3.38) 1.53 (0.90–2.58) 0.89 (0.38–2.08) 1.31 (0.53–3.24)
p-Value 0.15 0.25 0.36 0.12 0.79 0.55
CCP, cyclic citrullinated peptide; RF, rheumatoid factor.
201 cases missed the radiographic information.
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TaBle 5 | Assessment of interaction between HLA-DRB1 shared epitope (SE) (positive or negative) and cumulative smoking exposure (≥10 pack-years, <10 pack-
years, or never smoking) in rheumatoid arthritis (RA) risk in Chinese Han population.
Othera/
se-negative
heavy smoking/
se-negative
Other/se-positive heavy smoking/
se-positive
attributable proportion 
due to interaction
p-Value for 
interaction
Or (95% ci)
All RA Referent 1.46 (0.85–2.53) 2.77b (1.99–3.86) 3.81b (1.53–9.78) 0.17 (−0.61 to 0.94) 0.61
Anti-CCP antibody positive RA Referent 1.36 (0.76–2.43) 2.83b (2.01–3.99) 3.89b (1.50–10.09) 0.18 (−0.61 to 9.69) 0.81
Anti-CCP antibody negative RA Referent 1.61 (0.65–3.96) 2.98b (1.76–5.05) 3.24 (0.75–13.92) −0.11 (−1.72 to 1.50) 0.69
RFb positive RA Referent 1.58 (0.89–2.79) 2.85b (2.02–4.01) 3.83b (1.47–9.98) 0.11 (−0.75 to 0.96) 0.62
RF-negative RA Referent 0.67 (0.29–2.12) 3.13b (1.85–5.30) 3.67 (0.99–13.67) 0.21 (−0.86 to 1.28) 0.75
Radiographic erosions Referent 1.01 (0.55–1.85) 1.59 (0.44–5.70) 1.13 (0.22–5.88) −0.41 (−3.01 to 2.18) 0.75
aOther was defined as <10 pack-years smoking or never smoking.
bStatistical differences.
Smoking examined as ≥10 vs. <10 pack-years or never smoking. OR and corresponding 95% CI adjusted for sex, age. AP = 0 corresponds to no interaction and an AP = 1.0 
corresponds to “complete” additive interaction.
201 cases missed the radiographic information.
TaBle 4 | Assessment of interaction between HLA-DRB1 shared epitope (SE) (positive or negative) and smoking (ever or never) in rheumatoid arthritis (RA) risk in 
Chinese Han population.
never smoking/
se-negative
ever smoking/
se-negative
never smoking/
se-positive
ever smoking/
se-positive
attributable proportion 
due to interaction
p-Value for 
interaction
Or (95% ci)
All RA Referent 1.52 (0.88–2.60) 2.82a (2.01–3.95) 3.46a (1.50–7.95) 0.04 (−0.77 to 0.84) 0.37
Anti-CCP antibody positive RA Referent 1.41 (0.79–2.49) 2.86a (2.02–4.06) 3.62a (1.53–8.55) 0.10 (−0.68 to 0.87) 0.50
Anti-CCP antibody negative RA Referent 1.70 (0.69–4.19) 3.11a (1.83–5.29) 2.07 (0.66–10.37) −0.46 (−2.46 to 1.54) 0.24
RF-positive RA Referent 1.66 (0.91–2.82) 2.92a (2.07–4.14) 3.25a (1.36–7.75) −0.09 (−1.03 to 0.86) 0.26
RF-negative RA Referent 0.86 (0.32–2.27) 3.10a (1.81–5.30) 3.97a (1.88–12.88) 0.26 (−0.64 to 1.16) 0.81
Radiographic erosions Referent 1.22 (0.34–4.38) 1.03 (0.55–1.92) 1.45 (0.28–7.64) 0.13 (−1.45 to 1.72) 0.84
aStatistical differences.
Smoking examined as ever vs. never smoking. OR and corresponding 95% CI adjusted for sex, age. AP = 0 corresponds to no interaction and an AP = 1.0 corresponds to 
“complete” additive interaction.
201 cases missed the radiographic information.
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epidemiology studies from Korean, Japan, and China have previ-
ously not shown any association between smoking, HLA-DRB1, 
and ACPA-positive RA (9, 18, 19). In this study, we have recruited 
718 cases and 404 healthy controls, and logistic regression 
analysis can remove this bias caused by age and gender (16). In 
our study, smoking (either ever compared with never smokers, 
or cumulative dose) was non-significantly associated with both 
risk of RA-overall, and among ACPA-positive and -negative and 
RF-positive and RF-negative cases, and presence of baseline ero-
sions. We do not see a formal interaction between smoking and SE 
carriage in the development of ACPA-positive disease. However, 
greater increases in risk were seen for SE-positive smokers 
compared with either SE-negative smokers or SE-positive non-
smokers for RA-overall, ACPA-positive and -negative RA, and 
RF-positive and -negative RA, considering either ever compared 
with never smokers or cumulative smoking exposure. These find-
ings, while individually not statistically significant, are consistent 
with and support the presence of interaction between smoking, 
SE carriage, and the risk of RA. The similarity of findings of the 
effects of smoking and SE carriage between ACPA-positive and 
-negative RA suggests that the interaction is not restricted to 
ACPA-positive disease, as originally suggested.
Based on previous work, there were several significant dif-
ferences in the role of SE between Han Chinese and Caucasians. 
First, the prevalence of SE in Han Chinese is much lower than 
in Caucasians (Han 40% vs. Caucasians 70%) (5–7). Second, 
the SE subtypes found in Han Chinese and European-descent 
RA cases were different. European-descent RA cases have two 
main subtypes, HLA-DRB1*0401 and HLA-DRB1*0405, while 
Chinese have one main subtype, HLA-DRB1*0405. The preva-
lence of HLA-DRB1*0401 among Han Chinese and Asians is 
much lower than that in Caucasians (20). Interethnic HLA-DRB1 
subtype differences like this may explain the differences in our 
findings compared with those previously reported in European 
populations.
Another potential explanation for the different results in 
our study compared with previous studies is the proportion of 
smokers among RA cases. In studies that involving American or 
European subjects, more than half of the RA patients and more 
than 40% healthy people were ever smokers (2, 5). Smoking 
rates among Chinese women are much lower, with only 2.4% 
women being ever smokers (12). This is consistent with the low 
rate of smoking among females in our study. This would lead to 
lower power to identify an association between smoking and RA 
6Yin et al. Influence of Cigarette Smoking on RA Risk in the Han Chinese Population
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and to investigate interactions between smoking, HLA-DRB1, 
and RA.
It is also possible that smoking effects were obscured by 
high exposure to other environmental agents. For example, 
personal smoking effects could have been obscured by passive 
smoking, which we did not assess but which is a major public 
health problem in China. We also hypothesize that air pollution 
could play a role. While in Europe and USA air pollution was not 
associated with RA (21, 22), the very heavy air pollution found 
in major Chinese cities is a possible contributing factor. Indirect 
evidence only exists to support this hypothesis. First, a new 
study (23) found association between airway insults and peptide 
citrullinations in lungs suggesting that smoking-induced inflam-
mation, rather than smoking itself, contributes to an increase 
in citrullination in lungs. Second, in the Korea population, 
whose genetic background and SE constitution are similar with 
Chinese, but where air pollution is not as marked (24), the effect 
of smoking on RA risk is observed (9). Third, the prevalence of 
RA was higher in China than that in South Korea [0.37% (25) vs. 
0.27% (26)]. This phenomenon may be due to air pollution 
exposure being more prevalent than smoking. Fourth, smoking 
(27) as well as fine atmospheric particulates (PM2.5) (24) were 
reported to be associated with Oxidative Stress, so we speculate 
that high concentration of PM2.5 may obscure the effect of smok-
ing. Clarifying the relationship between PM2.5 and RA will help 
us learn more about the pathogenesis of RA.
In conclusion, this study provides support to the existence of 
interaction between smoking and HLA-DRB1 in the pathogenesis 
of RA. However, the effect is not as strong as reported in other East 
Asian countries or in European or North American studies. This 
may be related to statistical power, or an alternative explanation 
that greater exposure to other potential environmental factors 
may act as triggers for the disease, such as passive smoking and 
industrial air pollution, in China. Further studies will be required 
to investigate the potential role for these factors in RA.
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